More than 100,000 of us demanded Mylan drop the price of EpiPen. And last week Mylan responded to consumer outrage with a claim that they’re making EpiPen affordable for people who can’t afford it. But under the surface, the company didn’t actually change the price at all. The price cuts only apply to some underinsured consumers, who will get a $300 savings card. Everyone else, including anyone receiving Medicare or Medicaid, continues to pay the outrageous $600 price tag.

The American taxpayer funded the creation of the EpiPen, which was developed for the armed forces as the "ComboPen." And now Mylan has turned this life-saving device into a cash cow.

President Obama and the FDA have the authority to bust up the EpiPen monopoly. So Other98 is joining up with our friends at CREDO and Social Security Works to demand they do it. Add your name and tell President Obama to rein in these drug prices.

Mylan’s announcement shows that Big Pharma is in full damage-control mode. With an increasing outcry against skyrocketing prices, Mylan is likely hoping to take the heat off the monopoly system that allows companies like Mylan to make obscene profits off live-saving medicines in the first place.

The industry is vulnerable, and if we don’t act now, we’re going to playing whack-a-mole with these drug corporations: every time we beat one price-gouge, another one will pop right up.

President Obama has the power to bust up Pharma monopolies on life saving medicines and the EpiPen is a great start. With the stroke of a pen, he can instruct the Food and Drug Administration (FDA) to strip Mylan of its EpiPen monopoly and open the door to busting up other monopolies on medicine.  

If we can get the FDA to strip Mylan’s monopoly over EpiPen, it will set an incredibly powerful precedent and finally put us on the road to making quality healthcare a human right, not a privilege.